Most interestingly, Arora et al. showed that induction of glucocorticoid receptor (GR) expression is frequently found in enzalutamide resistant tumors and propose that in the presence of enzalutamide the GR may substitute for AR, by activating a certain subset of AR target genes, thereby promoting PCa progression [31]. Here, AR is linked to posterior cortical atrophy.